Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 50% on Thursday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares traded hands during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Price Performance
The firm’s 50 day moving average price is C$0.07 and its two-hundred day moving average price is C$0.06. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a market cap of C$13.95 million, a PE ratio of -10.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- ETF Screener: Uses and Step-by-Step Guide
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Comparing and Trading High PE Ratio Stocks
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Insider Trades May Not Tell You What You Think
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
